Merck & Co., Inc., Rahway, N.J., USA and Starpharma Sign Research Agreement

Australia’s Starpharma and Merck & Co., Inc., Rahway, N.J., USA have signed a research agreement allowing Merck & Co., Inc., Rahway, N.J., USA to conduct a preclinical research evaluation of dendrimer-based antibody-drug conjugates (ADCs) utilizing Starpharma’s proprietary DEP® technology.